+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sleep Apnea Devices Market, Industry Trends and Global Forecasts, till 2035 - Distribution by Product Type, Type of Diagnostic Device, Type of Therapeutic Device, Type of Positive Airway Pressure Device, Route of Administration and Key Geographical Regions

  • PDF Icon

    Report

  • 310 Pages
  • February 2024
  • Region: Global
  • Roots Analysis
  • ID: 5941168

Sleep Apnea Devices Market Surges with Record Funding and Patent Activity

The global sleep apnea devices market is estimated to be worth $13.5 billion in 2024 and is anticipated to grow at a CAGR of 4.61% during the forecast period from 2023 to 2035. This research study consists of industry trends, detailed market analysis, patent analysis, clinical trial analysis, funding and investment analysis and partnerships and collaborations analysis. The growth in the sleep apnea devices market share over the next decade is likely to be the result of anticipated increase in patient population and rise in the demand for sleep apnea devices for sleep apnea treatment.

Sleep apnea, used interchangeably with sleep apnoea, is one of the serious sleep disorders characterized by repeated start or stop in breathing during sleep. These interruptions in sleep can last up to several minutes. Sleep apnea can be broadly categorized into three types, obstructive sleep apnea, central sleep apnea and complex sleep apnea. Obstructive sleep apnea and central sleep apnea are the most common types of sleep apnea with similarity in symptoms, which include loud snoring, morning headache, excessive daytime sleepiness and dry mouth.

Sleep apnea is often an underdiagnosed condition that can affect all age groups. According to a study, obesity and excess weight is the most common cause of sleep apnea in adults. Additionally, modern lifestyle-related risk factors, such as smoking, alcohol consumption, lack of physical activity and psychological stress play a crucial role in the rapidly increasing prevalence of sleep apnea. As a result, medical experts are extensively focusing on developing effective, safe and versatile sleep apnea diagnosis and treatment options. Currently, several therapeutic devices are being employed for the treatment of sleep apnea. Owing to the rising disease burden of sleep apnea, as well as the ongoing research and development efforts to develop advanced obstructive sleep apnea medical devices, the sleep apnea devices market is anticipated to witness steady market growth during the forecast period.

Market Share Insights

The sleep apnea devices market research report presents an in-depth analysis of the various companies that are engaged in the global sleep apnea industry, across different segments, as defined below:

  • Historical Trend: 2018-2022
  • Base Year: 2023
  • Forecast Period: 2024-2035
  • Sleep Apnea Devices Market 2024: $13.05 Billion
  • CAGR: 4.61%
  • PowerPoint Presentation: (Complimentary)
  • Customization Scope: 15% Free Customization
  • Product Type 
    • Sleep Apnea Medical Devices
    • Sleep Apnea Drug Therapies
  • Type of Diagnostic Device 
    • Polysomnography Devices
    • Home Sleep Apnea Testing Devices
  • Type of Therapeutic Device
    • Positive Airway Pressure Devices
    • Oral Devices
    • Implantable Devices
  • Type of Positive Airway Pressure Device
    • CPAP Machine
    • BiPAP Machines
    • APAP Machines
    • Other Machines
  • Route of Administration
    • Oral Therapies
    • Subcutaneous Therapies
  • Key Geographical Regions
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World
  • Key Companies Profiled
    • Acurable
    • Advanced Brain Monitoring
    • Airway Management
    • Apnimed
    • Bayer
    • Belun Technology
    • BRAEBON Medical
    • Cadwell
    • Desitin Pharma
    • Drive DeVilbiss Healthcare
    • Eli Lilly and Company
    • Hunan Ventmed Medical Technology
    • Incannex Healthcare
    • Löwenstein Medical
    • Nihon Kohden
    • Nox Medical
    • Oventus Medical
    • Philips
    • React Health
    • ResMed
    • SciSparc
    • Sibelmed
    • Somnetics International inc
    • SomnoMed
    • Sunrise
    • Topson Medical
    • Vyaire Medical
    • Wellue
    • Whole You
    • ZOLL Itamar
    • (Full list of 110+ companies captured is available in the report)
  • Excel Data Packs: (Complimentary)
    • Market Landscape Analysis
    • Clinical Trial Analysis
    • Partnership and Collaboration Analysis
    • Funding and Investment Analysis
    • Patent Analysis
    • Market Forecast an Opportunity Analysis

Segmental Overview

Market Share by Product Type

The global sleep apnea market highlights the distribution of this segment across different types of products, such as sleep apnea medical devices and drug therapies. The sleep apnea devices market segment occupies the highest share in 2024 and is expected to witness substantial growth in the coming years.

Market Share by Type of Diagnostic Device

The global sleep apnea diagnostic devices market is categorized into polysomnography devices and home sleep apnea testing devices. The home sleep apnea testing devices segment occupies the highest sleep apnea devices market share for diagnosis in 2024 and expected to dominant during the forecast period. This can be primarily attributed to the fact that such devices offer a convenient and cost-effective way to monitor and diagnose sleep apnea from the comfort of their homes.

Market Share by Type of Therapeutic Device

The global sleep apnea therapeutic devices market is segmented into positive airway pressure devices, oral devices and implantable devices. Owing to their comfortable and convenient nature oral devices are likely to grow at a higher CAGR as compared to other devices in the coming years.

Market Share by Key Geographical Regions

This segment highlights the distribution of sleep apnea drugs market and sleep apnea devices market share across various geographies, such as North America, Europe, Asia-Pacific and Rest of the World. According to projections, the sleep apnea devices market in North America is likely to capture majority (70%) of the market share, and this trend is unlikely to change in the future. It is worth highlighting that the market in Asia-Pacific is expected to grow at a relatively healthy CAGR (9%), during the period 2024-2035.

Key Market Insights

The market report features an extensive study of the current market landscape, sleep apnea devices market share, market size, market analysis, market forecast and future opportunities for the sleep apnea companies involved in the development of sleep apnea medical devices and sleep apnea drugs. The sleep apnea devices market research report highlights the efforts of several sleep apnea device manufacturers and sleep apnea therapy developers engaged in this rapidly emerging market segment of the pharmaceutical industry. Key takeaways of the sleep apnea devices market report are briefly discussed below.

Rising Prevalence of Obstructive Sleep Apnea and Central Sleep Apnea

Sleep apnea is an underrecognized medical condition that is more common in men than women and prevalence of sleep apnea tend to rise with age in the general population. It is estimated that nearly 1 billion people have mild to severe sleep apnea globally, however, a substantial portion of this population remains undiagnosed. In Europe, sleep apnea has emerged as one of the key public health problems. In fact, nearly 90 million (22.7%) people have moderate to severe obstructive sleep apnea in Europe. Similarly, around 7% of the total population and 60% of the geriatric population aged 65 and above is suffering from obstructive sleep apnea in the US. It is worth highlighting that improved detection and diagnosis of sleep apnea has also contributed to the growing number of reported cases of this clinical condition.

Competitive Landscape of Sleep Apnea Device Manufacturers

The sleep apnea device manufacturers landscape features over 100 companies offering a range of sleep apnea medical devices, including continuous positive airway pressure machines (CPAP machine), bilevel positive airway pressure machines (BiPAP), auto-adjusting pressure machines (APAP), oral devices, implantable devices, contactless devices, adaptive servo ventilation, expiratory positive airway pressure devices, home sleep apnea test devices and polysomnography devices. Notably, the majority of the sleep apnea medical devices can be used in home care setting for the diagnosis and treatment of sleep apnea, with an aim to enhance the overall experience of end user. Some examples of obstructive sleep apnea medical devices include O2Vent Optima Mini, aura6000™, AirSense™ 11 CPAP and Bongo Rx. Overall, the market landscape of sleep apnea medical device manufacturers is well-fragmented, featuring the presence of small, mid-sized, and large sleep apnea companies located in different geographical regions.

It is interesting to note that around 50% of these sleep apnea device manufacturers are located in North America, followed by Europe. Within North America, US and Canada emerged as the hubs for sleep apnea device manufacturers. It is worth highlighting that Appscent Medical, an Israel based company, is developing an advanced artificial intelligence-based home care medical device for contactless detection and treatment of sleep apnea, which is expected to revolutionize the sleep apnea treatment in the coming years. In addition, Resmed captures the significant sleep apnea devices market share for both diagnostic and treatment devices. Furthermore, amidst the recent initiatives undertaken to develop more convenient treatment options for this medical condition, sleep apnea nasal devices have emerged as one of the most suitable options, having demonstrated the capability to treat sleep apnea.

Competitive Landscape of Sleep Apnea Drug Therapy Developers

Sleep apnea drugs market features the presence of close to 25 industry and non-industry players developing / evaluating drug therapies for sleep apnea treatment. Over 35 sleep apnea drug therapies are currently being evaluated in different phases of clinical studies, either as monotherapies or in combination with other drugs for the treatment of obstructive sleep apnea and central sleep apnea. It is worth highlighting that, in June 2022, Apnimed received fast track designation from the USFDA for its novel oral pharmacologic combination for sleep apnea treatment. Further, in October 2022, Eli Lilly and Company received the fast-track designation for its single novel molecule tirzepatide for sleep apnea treatment.

Sleep Apnea Devices Market Trends Analysis: Increase in Funding and Patent Activity Reflect the Rising Interest in this Industry

In the past four years, close to USD 1.6 billion have been invested by various investors across the globe in sleep apnea companies engaged in the sleep apnea devices market. These companies raised majority of the funds through other equity. It is worth highlighting that LivaNova raised a significant capital amount (USD 595 million) through other equity. The company has planned to use this amount to advance its neurostimulator therapeutic device for sleep apnea treatment.

Additionally, over 1,600 patents focused on sleep apnea have been granted / filed in the past four years, indicating the substantial efforts made by researchers engaged in this domain. Most of the patents have been filed for the advancement of sleep apnea medical devices.

Sleep Apnea Devices Market Analysis: Sleep Apnea Therapeutic Devices Hold Majority Market Share

The global sleep apnea devices market is estimated to be worth USD 13.5 billion in 2024. The market growth is expected to be driven by the growing geriatric population, rising demand for sleep apnea therapeutic devices leading to a CAGR of 4.61% and carve out a significant sleep apnea devices market share over the forecast period.

Regional Analysis: North America Emerged as the Hub of Sleep Apnea Medical Devices and Sleep Apnea Treatment; Asia Pacific to be the Fastest Growing Market

Presently, North America capture 70% of the market share of the overall sleep apnea devices market. In the recent years, demand for sleep apnea devices has witnessed a tremendous increase in North America. Further, it is worth highlighting that, owing to the rising demand for sleep apnea devices and anticipated drug approvals, market in Asia Pacific is likely to grow at a higher CAGR as compared to other regions in the coming years.

Key Sleep Apnea Companies Involved in Sleep Apnea Market

Examples of key sleep apnea companies in sleep apnea market (the complete list of companies is available in the full report) include Acurable, Advanced Brain Monitoring, Airway Management, Apnimed, Bayer, Belun Technology, Braebon Medical, Cadwell, Desitin Pharma, Drive DeVilbiss Healthcare, Eli Lilly and Company, Fisher Paykel, Hunan VentMed Medical Technology, Incannex Healthcare, Löwenstein Medical, Natus Medical, Nox Medical, Oventus Medical, Philips, React Health, ResMed, SciSparc, Sibelmed, Somnetics International inc, SomnoMed, Sunrise, Topson Medical, Vyaire Medical, Wellue, Whole You and ZOLL Itamar. This global sleep apnea market research report includes an easily searchable excel database of all the companies that have capability to offer sleep apnea devices (such as cpap machine) or engaged in developing sleep apnea drugs worldwide.

Recent Developments in Sleep Apnea Devices Market

Several recent developments have taken place in the field of sleep apnea devices market, some of which have been outlined below. These developments, even if they took place post the release of the sleep apnea devices market report, substantiate the overall sleep apnea devices market trends that the analyst has outlined in the analysis:

  • In June 2023, the US-based Inspire Medical Systems received an expanded FDA approval for its neurostimulation technology based medical device, an alternative of traditional CPAP machine for sleep apnea treatment. This expanded approval is expected to enable the company to offer its device to patients with severe obstructive sleep apnea.
  • In June 2023, Fisher Paykel signed a product / technology integration agreement with VGM & Associate, a US based hospital. Under the terms of the agreement, Fisher Paykel announced its plans to use myAirvo line of product to support VGM members.

Report Coverage

The sleep apnea devices market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different geographies. Amongst other elements, the market report includes:

  • A preface provides an introduction to the full report, Sleep Apnea Devices Market, Industry Trends and Global Forecasts, till 2035.
  • An outline of the systematic research methodology adopted to conduct the study on sleep apnea devices market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure accuracy and reliability of these findings.
  • An overview of economic factors that impact the overall sleep apnea devices market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
  • An executive summary of the key insights captured during the research, offering a high-level view on the current landscape of the sleep apnea medical devices and sleep apnea drug therapies and its likely evolution in the short to mid and long term.
  • A general overview of sleep apnea, highlighting details on different types of sleep apnea and its impact on health. It also features the various devices available for the diagnosis and treatment of sleep apnea. Further, it provides information on the drug therapies being investigated for sleep apnea.
  • A comprehensive assessment of the overall market landscape of diagnostic devices for detection of sleep apnea, based on several relevant parameters, such as type of device (polysomnography devices and home sleep apnea testing devices), physiological parameters monitored (heart rate, blood oxygen level, body position, snoring, chest motion, sleep stages and others), type of sleep apnea diagnosed (obstructive sleep apnea, central sleep apnea and complex sleep apnea), device connectivity (bluetooth, cellular, wi-fi and others / undisclosed), target patient segment (adults, children and elderly adults), end user (home care settings and individuals, hospitals / clinics and others) and price. In addition, the chapter features information on various device developers, along with analysis based on multiple parameters, such as year of establishment, company size and location of headquarters.
  • A detailed assessment of the overall market landscape of the sleep apnea therapeutic devices for sleep apnea treatment, based on several relevant parameters, such as type of sleep apnea treated (obstructive sleep apnea, central sleep apnea and complex sleep apnea), therapeutic principle (airway pressure, jaw and tongue stabilization, neurostimulation, physiological monitoring and others), type of device (oral devices, AutoPAP, BiPAP, CPAP, implanted devices, adaptive servo ventilation, EPAP, contactless devices and others), type of mask (nasal masks, full face masks and nasal pillow masks), type of treatment, device connectivity (bluetooth, cellular, wi-fi and others / undisclosed), type of storage offered (SD card, cloud platform, USB drive and web portal), target patient segment (adults, elderly adults and children), end user (home care settings and individuals, hospitals / clinics and others) and price. In addition, the chapter features information on various device developers, along with analysis based on multiple parameters, such as year of establishment, company size, location of headquarters and most active players (in terms of number of products developed).
  • A detailed overview of the current market landscape of the sleep apnea drug therapies currently under development for sleep apnea treatment, based on several relevant parameters, such as phase of development (phase III, phase II and phase I), type of therapy (monotherapy and combination therapy), route of administration (oral, nasal, intravenous and subcutaneous), number of doses (multiple doses and single dose) and target patient segment (adults and elderly adults, adults and children). In addition, the chapter features information on various therapy developers, along with analysis based on multiple parameters, such as year of establishment, company size and location of headquarters.
  • Elaborate profiles of prominent companies (shortlisted based on product portfolio strength) engaged in sleep apnea market. Each profile features a brief overview of the company (including information on year of establishment, number of employees, location of headquarters and leadership team), details related to product portfolio, recent developments and an informed future outlook.
  • An insightful clinical trial analysis of completed / ongoing clinical trials related to sleep apnea, based on various relevant parameters, such as trial registration year, trial phase, trial status, type of sponsor / collaborator, study design, trial focus area, number of patients enrolled, most active players (based on the number of clinical trials conducted) and geography.
  • A detailed analysis of the partnerships inked between stakeholders in sleep apnea market, since 2017, covering acquisitions, product / technology integration agreements, distribution agreements, service alliances, commercialization agreements, research agreements and other relevant agreements.
  • An analysis of the funding and investments made in sleep apnea companies, since 2019, through seed financing, venture capital financing, IPOs, secondary offerings, grants / awards, private placements, other equity and debt financing, at various stages of development of such companies, based on several parameters, such as year of investment, amount invested, type of funding, investment focus area, leading players, key investors, and geographical analysis.
  • An in-depth analysis of various patents that have been filed / granted related to sleep apnea, since 2019, taking into consideration parameters, such as type of patent, patent publication year, patent jurisdiction, cooperative patent classification (CPC) symbols, type of applicant, leading industry players (in terms of number of patents filed) leading non-industry players (in terms of number of patents filed) and leading individual assignees (in terms of number of patents filed). In addition, the chapter includes a detailed patent benchmarking analysis, highlighting key stakeholders and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
  • An in-depth analysis of the factors that can impact the growth of sleep apnea devices market. It also features identification and analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
  • A detailed estimate of the current sleep apnea devices market size, opportunity and the future growth potential of the sleep apnea market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the sleep apnea devices market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea market. Further, in order to account for future uncertainties and to add robustness to the model, the analyst has provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • A detailed projections of the current and future sleep apnea market across different type of product, such as sleep apnea medical devices and drug therapies.
  • A detailed estimate of the current market size, opportunity and the future growth potential of the sleep apnea diagnostic devices market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea diagnostic devices market. Further, in order to account for future uncertainties and to add robustness to the model, the analyst has provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • A detailed projections of the current and future sleep apnea diagnostic devices market across different types of devices, such as polysomnography device and home sleep apnea testing device.
  • A detailed projection of the current and future sleep apnea diagnostic devices market across key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.
  • A detailed estimate of the current market size, opportunity and the future growth potential of the sleep apnea therapeutic devices market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea therapeutic devices market. Further, in order to account for future uncertainties and to add robustness to the model, the analyst has provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • A detailed projections of the current and future sleep apnea therapeutic devices market across different types of devices, such as PAP devices, oral devices and implantable devices.
  • A detailed projection of the current and future sleep apnea therapeutic devices market across different types of PAP devices, such as APAP, BiPAP, CPAP and other devices.
  • A detailed projections of the current and future sleep apnea therapeutic devices market across key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.
  • A detailed estimate of the future growth potential of the sleep apnea drug therapies market over the next decade. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the market evolution during the forecast period. The report also features the likely distribution of the current and forecasted opportunity within the sleep apnea therapies market. Further, in order to account for future uncertainties and to add robustness to the model, the analyst has provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
  • A detailed projections of the future sleep apnea drug therapies market across different routes of administration, such as oral therapies and subcutaneous therapies.
  • A detailed projections of the future sleep apnea drug therapies market across key geographical regions, such as North America, Europe, Asia-Pacific and Rest of the World.

One of the key objectives of this market report was to estimate the current sleep apnea devices market share, opportunity and the future growth potential of the sleep apnea devices market, over the forecast period. Based on multiple parameters, likely adoption trends and through primary validations, the analyst has provided an informed estimate on the sleep apnea devices market evolution during the forecast period 2024-2035.

The sleep apnea devices market report also features the likely distribution of the current and forecasted opportunity within the sleep apnea devices market across various segments, such as product type (sleep apnea medical devices and drug therapies), type of diagnostic device (polysomnography devices and home sleep apnea testing devices), type of therapeutic device (positive airway pressure devices, oral devices and implantable devices), type of positive airway pressure device (CPAP machine, BiPAP machines, APAP machines and other machines), route of administration (oral therapies and subcutaneous therapies) and key geographical regions (North America, Europe, Asia-Pacific and Rest of the World).

In order to account for future uncertainties and to add robustness to the model, the analyst has provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Table of Contents

1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5 Research Methodology
1.6. Frequently Asked Questions
1.7. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact / Related Factors
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Future Estimates
3.2.2. Currency Coverage
3.2.2.1. Overview of Major Currencies Affecting the Market
3.2.2.2. Impact of Currency Fluctuations on the Industry
3.2.3. Foreign Exchange Impact
3.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
3.2.3.2. Strategies for Mitigating Foreign Exchange Risk
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. Chapter Overview
5.2. Introduction to Sleep Apnea
5.3. Type of Sleep Apnea
5.3.1. Obstructive Sleep Apnea
5.3.2. Central Sleep Apnea
5.3.3. Complex Sleep Apnea
5.4. The Impact of Sleep Apnea on Health
5.5. Diagnosis of Sleep Apnea
5.6. Treatment of Sleep Apnea
5.6.1. Therapeutic Devices for Sleep Apnea
5.6.2. Drug Therapies for Sleep Apnea
5.7. Concluding Remarks
6. SLEEP APNEA DIAGNOSTIC DEVICES: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Sleep Apnea Diagnostic Devices: Overall Market Landscape
6.2.1. Analysis by Type of Device
6.2.2. Analysis by Physiological Parameters Monitored
6.2.3. Analysis by Type of Sleep Apnea Diagnosed
6.2.4. Analysis by Device Connectivity
6.2.5. Analysis by Target Patient Segment
6.2.6. Analysis by End User
6.2.7. Analysis by Price
6.3. Sleep Apnea Diagnostic Devices: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Company Size and Location of Headquarters
7. SLEEP APNEA THERAPEUTIC DEVICES: MARKET LANDSCAPE
7.1. Chapter Overview
7.2. Sleep Apnea Therapeutic Devices: Overall Market Landscape
7.2.1. Analysis by Type of Sleep Apnea Treated
7.2.2. Analysis by Therapeutic Principle
7.2.3. Analysis by Type of Device
7.2.4. Analysis by Type of Mask
7.2.5. Analysis by Type of Treatment
7.2.6. Analysis by Device Connectivity
7.2.7. Analysis by Type of Storage Offered
7.2.8. Analysis by Target Patient Segment
7.2.9. Analysis by End User
7.2.10. Analysis by Price
7.3. Sleep Apnea Therapeutic Devices: Developer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Analysis by Company Size and Location of Headquarters
7.3.5. Most Active Players: Analysis by Number of Products
8. SLEEP APNEA DRUG THERAPIES: MARKET OVERVIEW
8.1. Chapter Overview
8.2. Sleep Apnea Drug Therapies: Overall Market Landscape
8.2.1. Analysis by Phase of Development
8.2.2. Analysis by Type of Drug Therapy
8.2.3. Analysis by Route of Administration
8.2.4. Analysis by Number of Doses
8.2.5. Analysis by Target Patient Segment
8.3. Sleep Apnea: Developer Landscape (Industry Players)
8.3.1. Analysis by Year of Establishment
8.3.2. Analysis by Company Size
8.3.3. Analysis by Location of Headquarters
8.3.4. Analysis by Company Size and Location of Headquarters
9. COMPANY PROFILES: SLEEP APNEA DIAGNOSTIC DEVICE DEVELOPERS
9.1. Chapter Overview
9.2. Cadwell
9.2.1. Company Overview
9.2.2. Device Portfolio
9.2.3. Recent Developments and Future Outlook
9.3. Itamar Medical
9.3.1. Company Overview
9.3.2. Device Portfolio
9.3.3. Recent Developments and Future Outlook
9.4. Nox Medical
9.4.1. Company Overview
9.4.2. Device Portfolio
9.4.3. Recent Developments and Future Outlook
9.5. Other Leading Diagnostic Device Developers
9.5.1. Acurable
9.5.2. Advanced Brain Monitoring
9.5.3. Belun Technology
9.5.4. Braebon Medical
9.5.5. Nihon Kohden
9.5.6. Sibelmed
9.5.7. Sunrise
9.5.8. Vyaire Medical
9.5.9. Wellue
10. COMPANY PROFILES: SLEEP APNEA THERAPEUTIC DEVICE DEVELOPERS
10.1. Chapter Overview
10.2. Löwenstein Medical
10.2.1. Company Overview
10.2.2. Device Portfolio
10.2.3. Recent Developments and Future Outlook
10.3. ResMed
10.3.1. Company Overview
10.3.2. Device Portfolio
10.3.3. Recent Developments and Future Outlook
10.4. SomnoMed
10.4.1. Company Overview
10.4.2. Device Portfolio
10.4.3. Recent Developments and Future Outlook
10.5. Other Leading Therapeutic Device Developers
10.5.1. Airway Management
10.5.2. Drive DeVilbiss Healthcare
10.5.3. Hunan VentMed Medical Technology
10.5.4. Oventus
10.5.5. Philips
10.5.6. React Health
10.5.7. Somnetics International
10.5.8. Topson Medical
10.5.9. Whole You
11. COMPANY PROFILES: SLEEP APNEA DRUG THERAPY DEVELOPERS
11.1. Chapter Overview
11.2. Apnimed
11.2.1. Company Overview
11.2.2. Drug Therapy Portfolio
11.2.3. Recent Developments and Future Outlook
11.3. Desitin Pharma
11.3.1. Company Overview
11.3.2. Drug Therapy Portfolio
11.3.3. Recent Developments and Future Outlook
11.4. Incannex Healthcare
11.4.1. Company Overview
11.4.2. Drug Therapy Portfolio
11.4.3. Recent Developments and Future Outlook
11.5. Other Leading Drug Therapy Developers
11.5.1. Bayer
11.5.2. Eli Lilly and Company
11.5.3. SciSparc
12. CLINICAL TRIAL ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Sleep Apnea: Clinical Trial Analysis
12.3.1. Analysis by Trial Registration Year
12.3.2. Analysis by Trial Phase
12.3.3. Analysis by Trial Status
12.3.4. Analysis by Trial Registration Year and Trial Status
12.3.5. Analysis by Type of Sponsor / Collaborator
12.3.6. Analysis by Study Design
12.3.6.1. Analysis by Type of Patient Allocation Model Used
12.3.6.2. Analysis by Type of Intervention
12.3.6.3. Analysis by Type of Trial Masking Adopted
12.3.6.4. Analysis by Trial Purpose
12.3.7. Analysis by Trial Focus Area
12.3.8. Analysis of Patients Enrolled by Trial Registration Year
12.3.9. Analysis of Patients Enrolled by Trial Phase
12.3.10. Most Active Industry Players: Analysis by Number of Clinical Trials
12.3.11. Most Active Non-Industry Players: Analysis by Number of Clinical Trials
12.3.12. Analysis of Clinical Trials by Geography
12.3.12.1. Analysis of Clinical Trials by Geography and Trial Status
12.3.12.2. Analysis of Patients Enrolled by Trial Status and Geography
13. PARTNERSHIPS AND COLLABORATIONS
13.1. Chapter Overview
13.2. Partnership Models
13.3. Sleep Apnea Therapies and Devices: Partnerships and Collaborations
13.3.1. Analysis by Year of Partnership
13.3.2. Analysis by Type of Partnership
13.3.3. Analysis by Year and Type of Partnership
13.3.4. Analysis by Type of Partner
13.3.5. Most Active Players: Analysis by Number of Partnerships
13.3.6. Analysis by Geography
13.3.6.1. Local and International Deals
13.3.6.2. Intercontinental and Intracontinental Deals
14. FUNDING AND INVESTMENT ANALYSIS
14.1. Chapter Overview
14.2. Types of Funding
14.3. Sleep Apnea: Funding and Investment Analysis
14.3.1. Analysis by Year of Investment
14.3.2. Analysis of Amount Invested by Year
14.3.3. Analysis by Type of Funding
14.3.4. Analysis of Amount Invested by Type of Funding
14.3.5. Analysis of Amount Invested by Year and Type of Funding
14.3.6. Analysis by Investment Focus Area
14.3.7. Most Active Players: Analysis by Number of Instances
14.3.8. Most Active Players: Analysis by Amount Raised
14.3.9. Analysis by Type of Investor
14.3.10. Leading Investors: Analysis by Number of Funding Instances
14.3.11. Analysis by Geography
14.3.11.1. Analysis of Instances by Geography
14.3.11.2. Analysis of Amount Invested by Geography
15. PATENT ANALYSIS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Sleep Apnea: Patent Analysis
15.3.1. Analysis by Type of Patent
15.3.2. Analysis by Patent Publication Year
15.3.3. Analysis by Type of Patent and Patent Publication Year
15.3.4. Analysis by Patent Jurisdiction
15.3.5. Analysis by CPC Symbols
15.3.6. Analysis by Type of Applicant
15.3.7. Leading Industry Players: Analysis by Number of Patents
15.3.8. Leading Non-Industry Players: Analysis by Number of Patents
15.3.9. Leading Individual Assignees: Analysis by Number of Patents
15.4. Sleep Apnea: Patent Benchmark Analysis
15.4.1. Analysis by Patent Characteristics
15.5. Patent Valuation Analysis
16. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
16.1. Chapter Overview
16.2. Market Drivers
16.3. Market Restraints
16.4. Market Opportunities
16.5. Market Challenges
16.6. Conclusion
17. GLOBAL SLEEP APNEA MARKET
17.1. Chapter Overview
17.2. Assumptions and Methodology
17.3. Global Sleep Apnea Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
17.3.1. Scenario Analysis
17.4. Key Market Segmentations
18. GLOBAL SLEEP APNEA MARKET BY TYPE OF PRODUCT
18.1. Chapter Overview
18.2. Assumptions and Methodology
18.3. Global Sleep Apnea Market: Distribution by Type of Product, 2018, 2023 and 2035
18.3.1. Sleep Apnea Medical Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
18.3.2. Drug Therapies: Forecasted Estimates (2025-2035)
18.4. Data Triangulation and Validation
19. GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET
19.1. Chapter Overview
19.2. Assumptions and Methodology
19.3. Scenario 1: Global Sleep Apnea Diagnostic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
19.3.1. Scenario Analysis
20. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF DIAGNOSTIC DEVICE
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Sleep Apnea Diagnostic Devices Market: Distribution by Type of Diagnostic Device, 2018, 2023 and 2035
20.3.1. Polysomnography Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.3.2. Home Sleep Apnea Testing Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
20.4. Data Triangulation and Validation
21. SLEEP APNEA DIAGNOSTIC DEVICES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Sleep Apnea Diagnostic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
21.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.3.4. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
21.4. Data Triangulation and Validation
22. GLOBAL SLEEP APNEA THERAPEUTIC DEVICES MARKET
22.1. Chapter Overview
22.2. Assumptions and Methodology
22.3. Global Sleep Apnea Therapeutic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
22.3.1. Scenario Analysis
23. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF THERAPEUTIC DEVICE
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Sleep Apnea Therapeutic Devices Market: Distribution by Type of Therapeutic Device, 2018, 2023 and 2035
23.3.1. PAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
23.3.2. Oral Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
23.3.3. Implanted Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
23.4. Data Triangulation and Validation
24. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY TYPE OF PAP DEVICE
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Sleep Apnea Therapeutic Devices Market: Distribution by Type of PAP Device, 2018, 2023 and 2035
24.3.1. CPAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.3.2. BiPAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.3.3. APAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.3.4. Other Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
24.4. Data Triangulation and Validation
25. SLEEP APNEA THERAPEUTIC DEVICES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS
25.1. Chapter Overview
25.2. Key Assumptions and Methodology
25.3. Sleep Apnea Therapeutic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
25.3.1. North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.3.2. Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.3.3. Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.3.4. Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
25.4. Data Triangulation and Validation
26. GLOBAL SLEEP APNEA DRUG THERAPIES MARKET
26.1. Chapter Overview
26.2. Assumptions and Methodology
26.3. Global Sleep Apnea Drug Therapies Market: Forecasted Estimates (2025-2035)
26.3.1. Scenario Analysis
26.4. Sleep Apnea Drug Therapies Market: Drug Therapy-Wise Sales Forecast, 2025-2035
27. SLEEP APNEA DRUG THERAPIES MARKET: DISTRIBUTION BY ROUTE OF ADMINISTRATION
27.1. Chapter Overview
27.2. Assumptions and Methodology
27.3. Sleep Apnea Drug Therapies Market: Distribution by Route of Administration, 2025 and 2035
27.3.1. Oral Drug Therapies Market: Forecasted Estimates (2026-2035)
27.3.2. Subcutaneous Drug Therapies Market: Forecasted Estimates (2025-2035)
28. SLEEP APNEA DRUG THERAPIES MARKET: DISTRIBUTION BY KEY GEOGRAPHICAL REGIONS
28.1. Chapter Overview
28.2. Key Assumptions and Methodology
28.3 Sleep Apnea Drug Therapies Market: Distribution by Key Geographical Regions, 2025 and 2035
28.3.1. North America: Forecasted Estimates (2025-2035)
28.3.1.1. US: Forecasted Estimates (2025-2035)
28.3.1.2. Mexico: Forecasted Estimates (2025-2035)
28.3.2. Europe: Forecasted Estimates (2026-2035)
28.3.2.1. Belgium: Forecasted Estimates (2027-2035)
28.3.2.2. Germany: Forecasted Estimates (2026-2035)
28.3.3. Asia-Pacific: Forecasted Estimates (2026-2035)
28.3.3.1. Australia: Forecasted Estimates (2026-2035)
28.3.3.2. China: Forecasted Estimates (2026-2035)
28.3.3.3. Japan: Forecasted Estimates (2026-2035)
28.3.3.4. Taiwan: Forecasted Estimates (2026-2035)
28.3.4. Rest of the World: Forecasted Estimates (2026-2035)
28.3.4.1. Brazil: Forecasted Estimates (2026-2035)
29. CONCLUSION30. APPENDIX 1: TABULATED DATA31. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 2.1 Research Methodology: Research Assumptions
Figure 2.2 Research Methodology: Project Methodology
Figure 2.3 Research Methodology: Forecast Methodology
Figure 2.4 Research Methodology: Robust Quality Control
Figure 2.5 Research Methodology: Key Market Segmentations
Figure 3.1 Lessons Learnt from Past Recessions
Figure 4.1 Executive Summary: Sleep Apnea Diagnostic Devices: Market Landscape
Figure 4.2 Executive Summary: Sleep Apnea Diagnostic Devices: Developers Landscape
Figure 4.3 Executive Summary: Sleep Apnea Therapeutic Devices: Market Landscape
Figure 4.4 Executive Summary: Sleep Apnea Drug Therapies: Market Overview
Figure 4.5 Executive Summary: Clinical Trial Analysis
Figure 4.6 Executive Summary: Partnerships and Collaborations
Figure 4.7 Executive Summary: Funding and Investment Analysis
Figure 4.8 Executive Summary: Patent Analysis
Figure 4.9 Executive Summary: Global Sleep Apnea Market: Market Forecast and Opportunity Analysis
Figure 4.10 Executive Summary: Sleep Apnea Diagnostic Devices: Market Forecast and Opportunity Analysis
Figure 4.11 Executive Summary: Sleep Apnea Therapeutic Devices: Market Forecast and Opportunity Analysis
Figure 4.12 Executive Summary: Sleep Apnea Drug Therapies: Market Forecast and Opportunity Analysis
Figure 5.1 Risk Factors and Symptoms Associated with Sleep Apnea
Figure 5.2 Health Consequences Associated with Sleep Apnea
Figure 6.1 Sleep Apnea Diagnostic Devices: Distribution by Type of Device
Figure 6.2 Sleep Apnea Diagnostic Devices: Distribution by Physiological Parameter Monitored
Figure 6.3 Sleep Apnea Diagnostic Devices: Distribution by Type of Sleep Apnea Diagnosed
Figure 6.4 Sleep Apnea Diagnostic Devices: Distribution by Device Connectivity
Figure 6.5 Sleep Apnea Diagnostic Devices: Distribution by Target Patient Segment
Figure 6.6 Sleep Apnea Diagnostic Devices: Distribution by End User
Figure 6.7 Sleep Apnea Diagnostic Devices: Distribution by Price (USD)
Figure 6.8 Sleep Apnea Diagnostic Device Developers: Distribution by Year of Establishment
Figure 6.9 Sleep Apnea Diagnostic Device Developers: Distribution by Company Size
Figure 6.10 Sleep Apnea Diagnostic Device Developers: Distribution by Location of Headquarters
Figure 6.11 Sleep Apnea Diagnostic Device Developers: Distribution by Company Size and Location of Headquarters
Figure 7.1 Sleep Apnea Therapeutic Devices: Distribution by Type of Sleep Apnea Treated
Figure 7.2 Sleep Apnea Therapeutic Devices: Distribution by Therapeutic Principle
Figure 7.3 Sleep Apnea Therapeutic Devices: Distribution by Type of Device
Figure 7.4 Sleep Apnea Therapeutic Devices: Distribution by Type of Mask
Figure 7.5 Sleep Apnea Therapeutic Devices: Distribution by Type of Treatment
Figure 7.6 Sleep Apnea Therapeutic Devices: Distribution by Device Connectivity
Figure 7.7 Sleep Apnea Therapeutic Devices: Distribution by Type of Storage Offered
Figure 7.8 Sleep Apnea Therapeutic Devices: Distribution by Target Patient Segment
Figure 7.9 Sleep Apnea Therapeutic Devices: Distribution by End User
Figure 7.10 Sleep Apnea Therapeutic Devices: Distribution by Price
Figure 7.11 Sleep Apnea Therapeutic Device Developers: Distribution by Year of Establishment
Figure 7.12 Sleep Apnea Therapeutic Device Developers: Distribution by Company Size
Figure 7.13 Sleep Apnea Therapeutic Device Developers: Distribution by Location of Headquarters
Figure 7.14 Sleep Apnea Therapeutic Device Developers: Distribution by Company Size and Location of Headquarters
Figure 7.15 Most Active Players: Distribution by Number of Products
Figure 8.1 Sleep Apnea Drug Therapies: Distribution by Phase of Development
Figure 8.2 Sleep Apnea Drug Therapies: Distribution by Type of Drug Therapy
Figure 8.3 Sleep Apnea Drug Therapies: Distribution by Route of Administration
Figure 8.4 Sleep Apnea Drug Therapies: Distribution by Number of Doses
Figure 8.5 Sleep Apnea Drug Therapies: Distribution by Target Patient Segment
Figure 8.6 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Year of Establishment
Figure 8.7 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Company Size
Figure 8.8 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Location of Headquarters (Region)
Figure 8.9 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Company Size and Location of Headquarters
Figure 12.1 Clinical Trial Analysis: Distribution by Trial Registration Year, 2019-2023
Figure 12.2 Clinical Trial Analysis: Distribution by Trial Phase
Figure 12.3 Clinical Trial Analysis: Distribution by Trial Status
Figure 12.4 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Status
Figure 12.5 Clinical Trial Analysis: Distribution by Type of Sponsor / Collaborator
Figure 12.6 Clinical Trial Analysis: Distribution by Type of Patient Allocation Model Used
Figure 12.7 Clinical Trial Analysis: Distribution by Type of Intervention
Figure 12.8 Clinical Trial Analysis: Distribution by Type of Trial Masking Adopted
Figure 12.9 Clinical Trial Analysis: Distribution by Trial Purpose
Figure 12.10 Clinical Trial Analysis: Distribution by Trial Focus Area
Figure 12.11 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Registration Year, 2019-2023
Figure 12.12 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Phase
Figure 12.13 Most Active Industry Players: Distribution by Number of Clinical Trials
Figure 12.14 Most Active Non-Industry Players: Distribution by Number of Clinical Trials
Figure 12.15 Clinical Trial Analysis: Distribution of Clinical Trials by Geography
Figure 12.16 Clinical Trial Analysis: Distribution of Clinical Trials by Geography and Trial Status
Figure 12.17 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Status and Geography
Figure 13.1 Partnerships and Collaborations: Cumulative Year-Wise Trend, 2017-2023
Figure13.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure13.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure13.4 Partnerships and Collaborations: Distribution by Type of Partner
Figure13.5 Most Active Players: Distribution by Number of Partnerships
Figure13.6 Partnerships and Collaborations: Distribution by Local and International Agreements
Figure13.7 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Deals
Figure 14.1 Funding and Investment Analysis: Cumulative Distribution of Number of Instances by Year, 2019-2023
Figure14.2 Funding and Investment Analysis: Cumulative Distribution of Amount Invested by Year, 2019-2023 (USD Million)
Figure14.3 Funding and Investment Analysis: Distribution by Type of Funding
Figure14.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Figure14.5 Funding and Investment Analysis: Distribution of Amount Invested (USD Million) by Year and Type of Funding, 2019-2023
Figure14.6 Funding and Investment Analysis: Distribution by Investment Focus Area
Figure14.7 Most Active Players: Distribution by Number of Instances
Figure14.8 Most Active Players: Distribution by Amount Raised (USD Million)
Figure14.9 Funding and Investment Analysis: Distribution by Type of Investor
Figure14.10 Leading Investors: Distribution by Number of Instances
Figure14.11 Funding and Investment Analysis: Distribution of Number of Instances by Geography
Figure14.12 Funding and Investment Analysis: Distribution of Amount Invested by Geography (USD Million)
Figure15.1 Patent Analysis: Distribution by Type of Patent
Figure15.2 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2019-2023
Figure 15.3 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Figure 15.4 Patent Analysis: Distribution by Patent Jurisdiction
Figure 15.5 Patent Analysis: Distribution by Top CPC Sections
Figure 15.6 Patent Analysis: Cumulative Distribution by Type of Applicant
Figure 15.7 Leading Industry Players: Distribution by Number of Patents
Figure 15.8 Leading Non-Industry Players: Distribution by Number of Patents
Figure 15.9 Leading Individual Assignees: Distribution by Number of Patents
Figure 15.10 Top CPC Codes: Benchmarking by Leading Industry Players
Figure 15.11 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Figure 15.12 Patent Analysis: Distribution by Patent Age
Figure 15.13 Patent Analysis: Valuation Analysis
Figure 16.1 Market Impact Analysis: Drivers
Figure 16.2 Market Impact Analysis: Restraints
Figure 16.3 Market Impact Analysis: Opportunities
Figure 16.4 Market Impact Analysis: Challenges
Figure 17.1 Global Sleep Apnea Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035): Base Scenario (USD Billion)
Figure 17.2 Global Sleep Apnea Market, Forecasted Estimates (2023-2035): Conservative Scenario (USD Billion)
Figure 17.3 Global Sleep Apnea Market, Forecasted Estimates (2023-2035): Optimistic Scenario (USD Billion)
Figure 18.1 Global Sleep Apnea Market: Distribution by Type of Product, 2018, 2023 and 2035
Figure 18.2 Sleep Apnea Medical Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 18.3 Drug Therapies: Forecasted Estimates (2025-2035)
Figure 19.1 Scenario 1: Sleep Apnea Diagnostic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.2 Scenario 2: Sleep Apnea Diagnostic Devices Market, Forecasted Estimates (2023-2035) (USD Billion)
Figure 19.3 Scenario 3: Sleep Apnea Diagnostic Devices Market, Forecasted Estimates (2023-2035) (USD Billion)
Figure 20.1 Sleep Apnea Diagnostic Devices Market: Distribution by Type of Diagnostic Device, 2018, 2023 and 2035
Figure 20.2 Polysomnography Devices Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 20.3 Home Sleep Apnea Testing Devices Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 21.1 Sleep Apnea Diagnostic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
Figure 21.2 Sleep Apnea Diagnostic Devices Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 21.3 Sleep Apnea Diagnostic Devices Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 21.4 Sleep Apnea Diagnostic Devices Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 21.5 Sleep Apnea Diagnostic Devices Market in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 22.1 Sleep Apnea Therapeutic Devices Market, Historical Trends (2018-2022) and Forecasted Estimates (2023-2035): Base Scenario (USD Billion)
Figure 22.2 Sleep Apnea Therapeutic Devices Market, Forecasted Estimates (2023-2035): Conservative Scenario (USD Billion)
Figure 22.3 Sleep Apnea Therapeutic Devices Market, Forecasted Estimates (2023-2035): Optimistic Scenario (USD Billion)
Figure 23.1 Sleep Apnea Therapeutic Devices Market: Distribution by Type of Therapeutic Device, 2018, 2023 and 2035
Figure 23.2 PAP Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 23.3 Oral Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 23.4 Implanted Devices: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035)
Figure 24.1 Sleep Apnea Therapeutic Devices Market: Distribution by Type of PAP Device, 2018, 2023 and 2035
Figure 24.2 CPAP Devices Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 24.3 BiPAP Devices Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 24.4 APAP Devices Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 24.5 Other Devices Market: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 25.1 Sleep Apnea Therapeutic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035
Figure 25.2 Sleep Apnea Therapeutic Devices Market in North America: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 25.3 Sleep Apnea Therapeutic Devices Market in Europe: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 25.4 Sleep Apnea Therapeutic Devices Market in Asia-Pacific: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 25.5 Sleep Apnea Therapeutic Devices Market in Rest of the World: Historical Trends (2018-2022) and Forecasted Estimates (2023-2035) (USD Billion)
Figure 26.1 Sleep Apnea Drug Therapies Market, Forecasted Estimates (2025-2035): Base Scenario (USD Million)
Figure 26.2 Sleep Apnea Drug Therapies Market, Forecasted Estimates (2025-2035): Conservative Scenario (USD Million)
Figure 26.3 Sleep Apnea Drug Therapies Market, Forecasted Estimates (2025-2035): Optimistic Scenario (USD Million)
Figure 26.4 AD109: Sales Forecast, 2026-2035 (USD Million)
Figure 26.5 Tirzepatide: Sales Forecast, 2025-2035 (USD Million)
Figure 26.6 AD504: Sales Forecast, 2027-2035 (USD Million)
Figure 26.7 IHL-42X: Sales Forecast, 2027-2035 (USD Million)
Figure 26.8 DST-096 (Sulthiame): Sales Forecast, 2027-2035 (USD Million)
Figure 26.9 AD182: Sales Forecast, 2026-2035 (USD Million)
Figure 26.10 AD036 / AD113 / AD816: Sales Forecast, 2027-2035 (USD Million)
Figure 27.1 Sleep Apnea Drug Therapies Market: Distribution by Route of Administration, 2025 and 2035
Figure 27.2 Oral Drug Therapies Market: Forecasted Estimates (2026-2035) (USD Million)
Figure 27.3 Subcutaneous Drug Therapies Market: Forecasted Estimates (2025-2035)
Figure 28.1 Sleep Apnea Drug Therapies Market: Distribution by Key Geographical Regions, 2025 and 2035
Figure 28.2 Sleep Apnea Drug Therapies Market in North America: Forecasted Estimates (2025-2035) (USD Million)
Figure 28.3 Sleep Apnea Drug Therapies Market in the US: Forecasted Estimates (2025-2035) (USD Million)
Figure 28.4 Sleep Apnea Drug Therapies Market in Mexico: Forecasted Estimates (2025-2035) (USD Million)
Figure 28.5 Sleep Apnea Drug Therapies Market in Europe: Forecasted Estimates (2026-2035) (USD Million)
Figure 28.6 Sleep Apnea Drug Therapies Market in Belgium: Forecasted Estimates (2027-2035) (USD Million)
Figure 28.7 Sleep Apnea Drug Therapies Market in Germany: Forecasted Estimates (2026-2035) (USD Million)
Figure 28.8 Sleep Apnea Drug Therapies Market in Asia-Pacific: Forecasted Estimates (2026-2035) (USD Million)
Figure 28.9 Sleep Apnea Drug Therapies Market in Australia: Forecasted Estimates (2026-2035) (USD Million)
Figure 28.10 Sleep Apnea Drug Therapies Market in China: Forecasted Estimates (2026-2035) (USD Million)
Figure 28.11 Sleep Apnea Drug Therapies Market in Japan: Forecasted Estimates (2026-2035) (USD Million)
Figure 28.12 Sleep Apnea Drug Therapies Market in Taiwan: Forecasted Estimates (2026-2035) (USD Million)
Figure 28.13 Sleep Apnea Drug Therapies Market in Rest of the World (Brazil): Forecasted Estimates (2026-2035) (USD Million)
Figure 29.1 Conclusion: Sleep Apnea Diagnostic Devices Market Landscape
Figure 29.2 Conclusion: Sleep Apnea Therapeutic Devices Market Landscape
Figure 29.3 Conclusion: Sleep Apnea Drug Therapies Market Landscape
Figure 29.4 Conclusion: Clinical Trial Analysis
Figure 29.5 Conclusion: Partnerships and Collaborations
Figure 29.6 Conclusion: Funding and Investment Analysis
Figure 29.7 Conclusion: Patent Analysis
Figure 29.8 Conclusion: Sleep Apnea Diagnostic Devices Market Forecast and Opportunity Analysis
Figure 29.9 Conclusion: Sleep Apnea Therapeutic Devices Market Forecast and Opportunity Analysis
Figure 29.10 Conclusion: Sleep Apnea Drug Therapies Market Forecast and Opportunity Analysis
LIST OF TABLES
Table 6.1 Sleep Apnea Diagnostic Devices: Information on Developer and Type of Device
Table 6.2 Sleep Apnea Diagnostic Devices: Information on Physiological Parameter Monitored
Table 6.3 Sleep Apnea Diagnostic Devices: Information on Type of Sleep Apnea Diagnosed
Table 6.4 Sleep Apnea Diagnostic Devices: Information on Device Connectivity
Table 6.5 Sleep Apnea Diagnostic Devices: Information on Target Patient Segment
Table 6.6 Sleep Apnea Diagnostic Devices: Information on End User and Price
Table 6.7 Sleep Apnea Diagnostic Devices: List of Developers
Table 7.1 Sleep Apnea Therapeutic Devices: Information on Developer and Type of Sleep Apnea Treated
Table 7.2 Sleep Apnea Therapeutic Devices: Information on Therapeutic Principle
Table 7.3 Sleep Apnea Therapeutic Devices: Information on Type of Device and Type of Mask
Table 7.4 Sleep Apnea Therapeutic Devices: Information on Type of Treatment
Table 7.5 Sleep Apnea Therapeutic Devices: Information on Device Connectivity and Type of Storage Offered
Table 7.6 Sleep Apnea Therapeutic Devices: Information on Target Patient Segment
Table 7.7 Sleep Apnea Therapeutic Devices: Information on End User and Price
Table 8.1 Sleep Apnea Drug Therapies: Information on Developer, Type of Player, Phase of Development and Type of Sleep Apnea Treated
Table 8.2 Sleep Apnea Drug Therapies: Information on Type of Drug Therapy, Route of Administration, Number of Doses and Target Patient Segment
Table 8.3 Sleep Apnea Drug Therapies: List of Drug Therapy Developers (Industry Players)
Table 9.1 Sleep Apnea Diagnostic Device Developers: List of Companies (Detailed Profiles)
Table 9.2 Sleep Apnea Diagnostic Device Developers: List of Companies (Tabulated Profiles)
Table 9.3 Cadwell: Company Overview
Table 9.4 Cadwell: Product Portfolio
Table 9.5 Cadwell: Recent Developments and Future Outlook
Table 9.6 Itamar Medical: Company Overview
Table 9.7 Itamar Medical: Product Portfolio
Table 9.8 Itamar Medical: Recent Developments and Future Outlook
Table 9.9 Nox Medical: Company Overview
Table 9.10 Nox Medical: Product Portfolio
Table 9.11 Nox Medical: Recent Developments and Future Outlook
Table 9.12 Acurable: Company Overview
Table 9.13 Acurable: Product Portfolio
Table 9.14 Advanced Brain Monitoring: Company Overview
Table 9.15 Advanced Brain Monitoring: Product Portfolio
Table 9.16 Belun Technology: Company Overview
Table 9.17 Belun Technology: Product Portfolio
Table 9.18 Braebon Medical: Company Overview
Table 9.19 Braebon Medical: Product Portfolio
Table 9.19 Nihon Kohden: Company Overview
Table 9.20 Nihon Kohden: Product Portfolio
Table 9.21 Sibelmed: Company Overview
Table 9.22 Sibelmed: Product Portfolio
Table 9.23 Sunrise: Company Overview
Table 9.24 Sunrise: Product Portfolio
Table 9.25 Vyaire Medical: Company Overview
Table 9.26 Vyaire Medical: Product Portfolio
Table 9.27 Wellue: Company Overview
Table 9.28 Wellue: Product Portfolio
Table 10.1 Sleep Apnea Therapeutic Device Developers: List of Companies (Detailed Profiles)
Table 10.2 Sleep Apnea Therapeutic Device Developers: List of Companies (Tabulated Profiles)
Table 10.3 Löwenstein Medical: Company Overview
Table 10.4 Söwenstein Medical: Device Portfolio
Table 10.5 ResMed: Company Overview
Table 10.6 ResMed: Device Portfolio
Table 10.7 ResMed: Recent Developments and Future Outlook
Table 10.8 SomnoMed: Company Overview
Table 10.9 SomnoMed: Device Portfolio
Table 10.10 SomnoMed: Recent Developments and Future Outlook
Table 10.11 Airway Management: Company Overview
Table 10.12 Airway Management: Device Portfolio
Table 10.13 Drive DeVilbiss Healthcare: Company Overview
Table 10.14 Drive DeVilbiss Healthcare: Device Portfolio
Table 10.15 Hunan VentMed Medical Technology: Company Overview
Table 10.16 Hunan VentMed Medical Technology: Device Portfolio
Table 10.17 Oventus: Company Overview
Table 10.18 Oventus: Device Portfolio
Table 10.19 Philips: Company Overview
Table 10.20 Philips: Device Portfolio
Table 10.21 React Health: Company Overview
Table 10.22 React Health: Device Portfolio
Table 10.23 Somnetics International: Company Overview
Table 10.24 Somnetics International: Device Portfolio
Table 10.25 Topson Medical: Company Overview
Table 10.26 Topson Medical: Device Portfolio
Table 10.27 Whole You: Company Overview
Table 10.28 Whole You: Device Portfolio
Table 11.1 Sleep Apnea Drug Therapy Developers: List of Companies (Detailed Profiles)
Table 11.2 Sleep Apnea Drug Therapy Developers: List of Companies Tabulated Profiles)
Table 11.3 Apnimed: Company Overview
Table 11.4 Apnimed: Drug Therapy Portfolio
Table 11.5 Apnimed: Recent Developments and Future Outlook
Table 11.6 Desitin Pharma: Company Overview
Table 11.7 Desitin Pharma: Drug Therapy Portfolio
Table 11.8 Desitin Pharma: Recent Developments and Future Outlook
Table 11.9 Incannex Healthcare: Company Overview
Table 11.10 Incannex Healthcare: Drug Therapy Portfolio
Table 11.11 Incannex Healthcare: Recent Developments and Future Outlook
Table 11.12 Bayer: Company Overview
Table 11.13 Bayer: Drug Therapy Portfolio
Table 11.14 Eli Lilly and Company: Company Overview
Table 11.15 Eli Lilly and Company: Drug Therapy Portfolio
Table 11.16 SciSparc: Company Overview
Table 11.17 SciSparc: Drug Therapy Portfolio
Table 13.1 Sleep Apnea Drug Therapies and Devices: List of Partnerships and Collaborations, 2017-2023
Table 14.1 Sleep Apnea: List of Funding and Investments, 2019-2023
Table 15.1 Patent Analysis: List of Top CPC Sections
Table 15.2 Patent Analysis: List of Top CPC Symbols
Table 15.3 Patent Analysis: List of Top CPC Codes
Table 15.4 Patent Analysis: Summary of Benchmarking Analysis
Table 15.5 Patent Analysis: Categorizations based on Relative Weighted Scores
Table 15.6 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 30.1 Sleep Apnea Diagnostic Devices: Distribution by Type of Device
Table 30.2 Sleep Apnea Diagnostic Devices: Distribution by Physiological Parameter Monitored
Table 30.3 Sleep Apnea Diagnostic Devices: Distribution by Type of Sleep Apnea Diagnosed
Table 30.4 Sleep Apnea Diagnostic Devices: Distribution by Device Connectivity
Table 30.5 Sleep Apnea Diagnostic Devices: Distribution by Target Patient Segment
Table 30.6 Sleep Apnea Diagnostic Devices: Distribution by End User
Table 30.7 Sleep Apnea Diagnostic Devices: Distribution by Price (USD)
Table 30.8 Sleep Apnea Diagnostic Device Developers: Distribution by Year of Establishment
Table 30.9 Sleep Apnea Diagnostic Device Developers: Distribution by Company Size
Table 30.10 Sleep Apnea Diagnostic Device Developers: Distribution by Location of Headquarters
Table 30.11 Sleep Apnea Diagnostic Device Developers: Distribution by Company Size and Location of Headquarters
Table 30.12 Sleep Apnea Therapeutic Devices: Distribution by Type of Sleep Apnea Treated
Table 30.13 Sleep Apnea Therapeutic Devices: Distribution by Therapeutic Principle
Table 30.14 Sleep Apnea Therapeutic Devices: Distribution by Type of Device
Table 30.15 Sleep Apnea Therapeutic Devices: Distribution by Type of Mask
Table 30.16 Sleep Apnea Therapeutic Devices: Distribution by Type of Treatment
Table 30.17 Sleep Apnea Therapeutic Devices: Distribution by Device Connectivity
Table 30.18 Sleep Apnea Therapeutic Devices: Distribution by Type of Storage Offered
Table 30.19 Sleep Apnea Therapeutic Devices: Distribution by Target Patient Segment
Table 30.20 Sleep Apnea Therapeutic Devices: Distribution by End User
Table 30.21 Sleep Apnea Therapeutic Devices: Distribution by Price
Table 30.22 Sleep Apnea Therapeutic Device Developers: Distribution by Year of Establishment
Table 30.23 Sleep Apnea Therapeutic Device Developers: Distribution by Company Size
Table 30.24 Sleep Apnea Therapeutic Device Developers: Distribution by Location of Headquarters
Table 30.25 Sleep Apnea Therapeutic Device Developers: Distribution by Company Size and Location of Headquarters
Table 30.26 Most Active Players: Distribution by Number of Products
Table 30.27 Sleep Apnea Drug Therapies: Distribution by Phase of Development
Table 30.28 Sleep Apnea Drug Therapies: Distribution by Type of Drug Therapy
Table 30.29 Sleep Apnea Drug Therapies: Distribution by Route of Administration
Table 30.30 Sleep Apnea Drug Therapies: Distribution by Number of Doses
Table 30.31 Sleep Apnea Drug Therapies: Distribution by Target Patient Segment
Table 30.32 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Year of Establishment
Table 30.33 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Company Size
Table 30.34 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Location of Headquarters (Region)
Table 30.35 Sleep Apnea Drug Therapy Developers (Industry Players): Distribution by Company Size and Location of Headquarters
Table 30.36 Clinical Trial Analysis: Distribution by Trial Registration Year, 2019-2023
Table 30.37 Clinical Trial Analysis: Distribution by Trial Phase
Table 30.38 Clinical Trial Analysis: Distribution by Trial Status
Table 30.39 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Status
Table 30.40 Clinical Trial Analysis: Distribution by Type of Sponsor / Collaborator
Table 30.41 Clinical Trial Analysis: Distribution by Type of Patient Allocation Model Used
Table 30.42 Clinical Trial Analysis: Distribution by Type of Intervention
Table 30.43 Clinical Trial Analysis: Distribution by Type of Trial Masking Adopted
Table 30.44 Clinical Trial Analysis: Distribution by Trial Purpose
Table 30.45 Clinical Trial Analysis: Distribution by Trial Focus Area
Table 30.46 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Registration Year, 2019-2023
Table 30.47 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Phase
Table 30.48 Most Active Industry Players: Distribution by Number of Clinical Trials
Table 30.49 Most Active Non-Industry Players: Distribution by Number of Clinical Trials
Table 30.50 Clinical Trial Analysis: Distribution of Clinical Trials by Geography
Table 30.51 Clinical Trial Analysis: Distribution of Clinical Trials by Geography and Trial Status
Table 30.52 Clinical Trial Analysis: Distribution of Patients Enrolled by Trial Status and Geography
Table 30.53 Partnerships and Collaborations: Cumulative Year-Wise Trend, 2017-2023
Table 30.54 Partnerships and Collaborations: Distribution by Type of Partnership
Table 30.55 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 30.56 Partnerships and Collaborations: Distribution by Type of Partner
Table 30.57 Most Active Players: Distribution by Number of Partnerships
Table 30.58 Partnerships and Collaborations: Distribution by Local and International Agreements
Table 30.59 Partnerships and Collaborations: Distribution by Intercontinental and Intracontinental Deals
Table 30.60 Funding and Investment Analysis: Cumulative Distribution of Number of Instances by Year, 2019-2023
Table 30.61 Funding and Investment Analysis: Cumulative Distribution of Amount Invested by Year, 2019-2023 (USD Million)
Table 30.62 Funding and Investment Analysis: Distribution by Type of Funding
Table 30.63 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 30.64 Funding and Investment Analysis: Distribution of Amount Invested (USD Million) by Year and Type of Funding, 2019-2023
Table 30.65 Funding and Investment Analysis: Distribution by Investment Focus Area
Table 30.66 Most Active Players: Distribution by Number of Instances
Table 30.67 Most Active Players: Distribution by Amount Raised (USD Million)
Table 30.68 Funding and Investment Analysis: Distribution by Type of Investor
Table 30.69 Leading Investors: Distribution by Number of Instances
Table 30.70 Funding and Investment Analysis: Distribution of Number of Instances by Geography
Table 30.71 Funding and Investment Analysis: Distribution of Amount Invested by Geography (USD Million)
Table 30.72 Patent Analysis: Distribution by Type of Patent
Table 30.73 Patent Analysis: Cumulative Distribution by Patent Publication Year, 2019-2023
Table 30.74 Patent Analysis: Distribution by Type of Patent and Patent Publication Year
Table 30.75 Patent Analysis: Distribution by Patent Jurisdiction
Table 30.76 Patent Analysis: Distribution by Top CPC Sections
Table 30.77 Patent Analysis: Cumulative Distribution by Type of Applicant
Table 30.78 Leading Industry Players: Distribution by Number of Patents
Table 30.79 Leading Non-Industry Players: Distribution by Number of Patents
Table 30.80 Leading Individual Assignees: Distribution by Number of Patents
Table 30.81 Top CPC Codes: Benchmarking by Leading Industry Players
Table 30.82 Leading Industry Players: Benchmarking by Patent Characteristics (CPC Codes)
Table 30.83 Patent Analysis: Distribution by Patent Age
Table 30.84 Patent Analysis: Valuation Analysis
Table 30.85 Global Sleep Apnea Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.86 Global Sleep Apnea Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.87 Global Sleep Apnea Market: Distribution by Type of Product, 2018, 2023 and 2035 (USD Billion)
Table 30.88 Sleep Apnea Medical Devices: Historical Trends, 2018-2022 (USD Billion)
Table 30.89 Sleep Apnea Medical Devices: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.90 Drug Therapies: Forecasted Estimates, 2025-2035 (USD Billion)
Table 30.91 Sleep Apnea Diagnostic Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.92 Sleep Apnea Diagnostic Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.93 Sleep Apnea Diagnostic Devices Market: Distribution by Type of Diagnostic Device, 2018, 2023 and 2035 (USD Billion)
Table 30.94 Polysomnography Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.95 Polysomnography Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.96 Home Sleep Apnea Testing Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.97 Home Sleep Apnea Testing Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.98 Sleep Apnea Diagnostic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Billion)
Table 30.99 Sleep Apnea Diagnostic Devices Market in North America: Historical Trends, 2018-2022 (USD Billion)
Table 30.100 Sleep Apnea Diagnostic Devices Market in North America: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.101 Sleep Apnea Diagnostic Devices Market in Europe: Historical Trends, 2018-2022 (USD Billion)
Table 30.102 Sleep Apnea Diagnostic Devices Market in Europe: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.103 Sleep Apnea Diagnostic Devices Market in Asia-Pacific: Historical Trends, 2018-2022 (USD Billion)
Table 30.104 Sleep Apnea Diagnostic Devices Market in Asia-Pacific: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.105 Sleep Apnea Diagnostic Devices Market in Rest of the World: Historical Trends, 2018-2022 (USD Billion)
Table 30.106 Sleep Apnea Diagnostic Devices Market in Rest of the World: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.107 Sleep Apnea Therapeutic Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.108 Sleep Apnea Therapeutic Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.109 Sleep Apnea Therapeutic Devices Market: Distribution by Type of Therapeutic Device, 2018, 2023 and 2035 (USD Billion)
Table 30.110 PAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.111 PAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.112 Oral Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.113 Oral Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.114 Implanted Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.115 Implanted Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.116 Sleep Apnea Therapeutic Devices Market: Distribution by Type of PAP Device, 2018, 2023 and 2035 (USD Billion)
Table 30.117 CPAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.118 CPAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.119 BiPAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.120 BiPAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.121 APAP Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.122 APAP Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.123 Other Devices Market: Historical Trends, 2018-2022 (USD Billion)
Table 30.124 Other Devices Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.125 Sleep Apnea Therapeutic Devices Market: Distribution by Key Geographical Regions, 2018, 2023 and 2035 (USD Billion)
Table 30.126 Sleep Apnea Therapeutic Devices Market in North America: Historical Trends, 2018-2022 (USD Billion)
Table 30.127 Sleep Apnea Therapeutic Devices Market in North America: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.128 Sleep Apnea Therapeutic Devices Market in Europe: Historical Trends, 2018-2022 (USD Billion)
Table 30.129 Sleep Apnea Therapeutic Devices Market in Europe: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.130 Sleep Apnea Therapeutic Devices Market in Asia-Pacific: Historical Trends, 2018-2022 (USD Billion)
Table 30.131 Sleep Apnea Therapeutic Devices Market in Asia-Pacific: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.132 Sleep Apnea Therapeutic Devices Market in Rest of the World: Historical Trends, 2018-2022 (USD Billion)
Table 30.133 Sleep Apnea Therapeutic Devices Market in Rest of the World: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Billion)
Table 30.134 Sleep Apnea Drug Therapies Market: Forecasted Estimates, 2025-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 30.135 AD109: Sales Forecast, 2026-2035 (USD Million)
Table 30.136 Tirzepatide: Sales Forecast, 2025-2035 (USD Million)
Table 30.137 AD504: Sales Forecast, 2027-2035 (USD Million)
Table 30.138 IHL-42X: Sales Forecast, 2027-2035 (USD Million)
Table 30.139 DST-096 (Sulthiame): Sales Forecast, 2027-2035 (USD Million)
Table 30.140 AD182: Sales Forecast, 2026-2035 (USD Million)
Table 30.141 AD036, AD113, AD816: Sales Forecast, 2027-2035 (USD Million)
Table 30.142 Sleep Apnea Drug Therapies Market: Distribution by Route of Administration, 2025 and 2035
Table 30.143 Oral Drug Therapies Market: Forecasted Estimates, 2025-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 30.144 Subcutaneous Drug Therapies Market: Forecasted Estimates, 2023-2035, Conservative, Base and Optimistic Scenarios (USD Million)
Table 30.145 Sleep Apnea Drug Therapies Market: Distribution by Key Geographical Regions, 2025 and 2035
Table 30.146 Sleep Apnea Drug Therapies Market in North America: Forecasted Estimates (2025-2035) (USD Million)
Table 30.147 Sleep Apnea Drug Therapies Market in the US: Forecasted Estimates (2025-2035) (USD Million)
Table 30.148 Sleep Apnea Drug Therapies Market in Mexico: Forecasted Estimates (2025-2035) (USD Million)
Table 30.149 Sleep Apnea Drug Therapies Market in Europe: Forecasted Estimates (2026-2035) (USD Million)
Table 30.150 Sleep Apnea Drug Therapies Market in Belgium: Forecasted Estimates (2027-2035) (USD Million)
Table 30.151 Sleep Apnea Drug Therapies Market in Germany: Forecasted Estimates (2026-2035) (USD Million)
Table 30.152 Sleep Apnea Drug Therapies Market in Asia-Pacific: Forecasted Estimates (2026-2035) (USD Million)
Table 30.153 Sleep Apnea Drug Therapies Market in Australia: Forecasted Estimates (2026-2035) (USD Million)
Table 30.154 Sleep Apnea Drug Therapies Market in China: Forecasted Estimates (2026-2035) (USD Million)
Table 30.155 Sleep Apnea Drug Therapies Market in Japan: Forecasted Estimates (2026-2035) (USD Million)
Table 30.156 Sleep Apnea Drug Therapies Market in Taiwan: Forecasted Estimates (2026-2035) (USD Million)
Table 30.157 Sleep Apnea Drug Therapies Market in Rest of the World (Brazil): Forecasted Estimates (2026-2035) (USD Million)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • 3D Sleep
  • Acare Technology
  • Acurable
  • Advanced Brain Monitoring
  • Aeonmed
  • Aeroflow Healthcare
  • AirAvant Medical
  • Airing
  • Airway Management
  • Alpha Wave Global
  • Ambu
  • Andersen
  • APIRx
  • Apnea Sciences
  • Apnimed
  • APP-NEA
  • Appscent
  • AppYea
  • Australian Pharmacy Sleep Services (acquired by Philips)
  • AvantSleep
  • Bayer
  • Belun Technology
  • Benco Dental
  • BetterNight
  • BioAnalytics
  • Bizdent Devices
  • BlueSom
  • BMC Medical
  • BOM Catalyzing Change
  • BPL Medical Technologies
  • Braebon Medical
  • Breas Medical
  • Bresotec Medical
  • Brevan Howard
  • Brigham & Womens Hospital
  • BRYGGS Medical
  • BYOND MEDICAL
  • Cadwell
  • Canadian Sleep Society
  • Candid Care
  • CardioVisual
  • Case Western Reserve University
  • Cerner
  • Clalit Research Institute
  • Cleveland Clinic 
  • CleveMed
  • Compumedics
  • COmputer Networks & SErvices Research laboraTory
  • Counties Manukau Health
  • Cure Pharmaceuticals
  • dbi services
  • Delta A Healthcare
  • Dentsply Sirona
  • Desitin Pharma
  • Dream Systems Dental Sleep Lab
  • Drive DeVilbiss Healthcare
  • DynaFlex
  • Ectosense (acquired by ResMed)
  • Eli Lilly and Company
  • Elmaslar Medikal
  • EnsoData
  • Entrusted Medical Devices
  • European Innovation Council
  • Evox
  • First Nation Group
  • Fisher & Paykel Healthcare
  • Fortrea
  • Frantz Design
  • Glidewell
  • GM Instruments
  • GOLDSLEEP
  • Great Lakes Dental Technologies
  • Hangzhou Dianzi University
  • HB Healthcare
  • huMannity Medtec
  • Hunan Ventmed Medical Technology
  • Imec
  • Incannex Healthcare
  • Inspire Medical Systems
  • Invacare
  • Invicta Medical
  • iSleep
  • Itamar Medical (a subsidiary of ZOLL Medical)
  • Jazz Pharmaceuticals
  • Kare Medical
  • keepMED
  • Kurma Partners
  • LeBlanc Dental
  • Linguaflex
  • LivaNova
  • Lofta
  • Luco Hybrid OSA Appliance
  • Löwenstein Medical
  • MEAHCo
  • MedAxiom
  • MedBridge Healthcare
  • Medicom MTD
  • Medifox Dan
  • Medit
  • Meinian Onehealth Healthcare
  • MicroDental Laboratories 
  • Morningside Ventures
  • Moses Appliances
  • MSD
  • MyCardio
  • Namur Invest
  • National Heart, Lung, and Blood Institute (NHLBI)
  • New West Dental Lab
  • Nexus Dental Systems
  • Nidek Medical
  • NightBalance
  • Nihon Kohden
  • NovaSom
  • Nox Medical
  • Nyxoah
  • Onera Health
  • Open Airway Dental Solutions
  • OrthoApnea
  • OSR Medical
  • Oventus Medical
  • Panthera Dental
  • PFL Healthcare
  • Philips
  • PranaQ
  • Pro Player Health Alliance
  • ProSomnus Sleep Technologies
  • QuietNITE
  • React Health
  • Remsleep
  • REMware
  • ResMed
  • Respo Gadgets
  • Resvent Medical 
  • S4S Dental
  • SCHEU DENTAL
  • SciSparc
  • Sectoral Asset Management
  • SEFAM
  • Segulah Medical Acceleration
  • Seligman Investments
  • Shenyang Rms Medical Tech 
  • Sibelmed
  • Side Health
  • Siesta Medical
  • Signifier Medical Technologies
  • Sleep Specialists
  • SLEEPON
  • SleepRes
  • SleepTight Mouthpiece
  • SleepX (acquired by AppYea)
  • SoClean
  • Sommetrics
  • Somnetics International
  • Somnics
  • SomnoMed
  • SOMNOmedics
  • Somnoware
  • Somnowell
  • South China Normal University
  • Spry Health
  • SUN YAT-SEN UNIVERSITY
  • Sunrise
  • Taisho Pharmaceutical
  • Takeda Pharmaceutical
  • Tao Capital Partners
  • The Pritzker Organization
  • TopSon Medical Technology
  • University Hospital, Antwerp
  • University Hospital, Grenoble
  • University of British Columbia
  • University of California, San Diego
  • University of Manitoba
  • University of Maryland
  • University of Rennes
  • VA Office of Research and Development
  • Vanderbilt University
  • Verily 
  • VGM & Associates
  • VIVES Inter-University Fund
  • Vivos Therapeutics
  • Vyaire Medical
  • Watermark Medical
  • Wellell
  • Wellue
  • ZOLL Medical

Methodology

 

 

Loading
LOADING...

Table Information